Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
VANIW was delisted on the 8th of September, 2022.
5 hedge funds and large institutions have $4.63K invested in Vivani Medical, Inc. Warrants expiring 03/14/2024 in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
58% less capital invested
Capital invested by funds: $11K → $4.63K (-$6.4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$588 |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$554 |
| 3 |
Morgan Stanley
New York
|
-$3 |
VANIW Hedge Fund Activity: Q3 2020 in Review
5 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) for Q3 2020, worth a combined $4.63K — down 58% from $11K a quarter earlier.
Fund positioning in VANIW was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was BNP Paribas Financial Markets, cutting an estimated $588.
- 5 institutional investors held Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $4.63K of Vivani Medical, Inc. Warrants expiring 03/14/2024 stock for Q3 2020, down 58% quarter-over-quarter.
- 0 funds opened new Vivani Medical, Inc. Warrants expiring 03/14/2024 positions in Q3 2020 and 0 closed out.
- The largest Vivani Medical, Inc. Warrants expiring 03/14/2024 seller in Q3 2020 was BNP Paribas Financial Markets, an estimated $588 sold.
Based on aggregated 13F filings for Q3 2020.